Skip to content
  • News
    • Amyloidosis – An Often Overlooked Disease with New Diagnostic and Treatment Options
    • Three medicinal products for the treatment of lipid disorders
    • Olezarsen for the treatment of hypertriglyceridemia
    • Clascoterone for the treatment of acne
    • French female athletes have been excluded from the World Championship by the World Boxing Federation.
    • Archive
  • Hypthalamus and puitary
    • Function of the Hypophysis
    • Acromegaly
    • Prolactinoma
    • Cushing’s Disease
    • Pituitary Adenomas
    • Craniopharyngiomas
    • Anterior Pituitary Insufficiency
      • Growth Hormone Deficiency (GHD) in Children
      • Growth hormone deficiency (GHD)
    • Diabetes Insipidus
    • SIADH (Syndrome of Inappropriate Antidiuretic Hormone Secretion)
  • Adrenals
    • Cushing’s Syndrome
    • Adrenal Cortex Carcinoma (Cushing’s Carcinoma)
    • Classical CAH (Congenital Adrenal Hyperplasia)
    • Adrenogenital Syndrome
    • Hyperaldosteronism
    • Pheochromocytoma
    • Adrenal Insufficiency
    • Adrenal Tumors
  • Thyroid
    • Cold nodules
    • Thyroid Cancer
    • Autonomous Adenoma
    • Hyperfunction (Hyperthyroidism)
      • Graves’ Disease (M. Basedow)
      • Endocrine Orbitopathy (EO)
    • Hypothyroidism (Hypothyreosis)
    • Chronic Autoimmune Thyroiditis (Hashimoto’s Thyroiditis)
    • Other Thyroid Inflammations
  • Parathyroid
    • Primary Hyperparathyroidism (pHPT)
    • Secondary Hyperparathyroidism (sHPT)
    • Tertiary Hyperparathyroidism (tHPT)
    • Neonatal Severe Hyperparathyroidism (NSHPT)
    • Hypercalcemia with Suppressed PTH
    • Hypoparathyroidism
    • Pseudo-Hypoparathyroidism (PHP)
    • Familial Hypocalciuric Hypercalcemia (FHH)
    • Autosomal Dominant Hypocalcemia (ADH)
  • Gonads
    • Testes (Male Gonads)
    • Hypergonadotropic Hypogonadism in Men
    • Testicular Tumors
    • Androgen Insensitivity
    • Ovaries
    • Amenorrhea
    • Polyendocrine Metabolic Ovarian Syndrome (PMOS)
    • Premature Ovarian Insufficiency (POI)
    • Functional Hypothalamic Amenorrhea (FHA)
    • Contraception
    • Precocious Puberty (Pubertas Praecox) in Girls
    • Delayed Puberty
    • Menopause
    • Developmental Disorders of Sex Differentiation
    • Sport and XY-DSD (Disorders of Sex Development)
    • Klinefelter Syndrome
    • Gender Incongruence trans women
    • Gender Incongruence trans men
    • Libido
    • Androgen Deficiency in Women
    • Clascoterone
    • Infertility
      • AMH (Anti-Müllerian Hormone),IVF, ICSI
      • Kisspeptin and Neurokinin B (NKB)
  • Neuroendocrine Tumor
    • Multiple Endokrine Neoplasien (MEN)
  • Osteoporosis
    • Osteoporosis: Screening and Diagnosis
    • Osteoporosistherapy
    • Exercises
    • Medications for Osteoporosis
    • Postmenopausal women
    • Osteoporosis in Men
    • Kyphoplasty
  • Lipidology
    • Epidemiology
    • Types of Lipid Metabolism Disorders
    • Who should be treated with a metabolic lipid disorder?
    • Cardiovascular Risk
      • Risk Management for Patients with Diabetes Mellitus
      • Risk Assessment Cardiovascular Disease
      • Lipid Therapy and Age
      • Unstable Plaques
    • Lipoproteins
    • Pharmacological Therapy
      • Statins
        • Adverse Effects of Statins
      • Ezetimibe
      • Bempedoic acid
      • Anion Exchange Resins
      • PCSK9 Inhibitors
      • PCSK9 synthesis inhibitor
      • Lyrokaul® (Lerodalcibep)
      • Obicetrapib
      • Fibrates
      • Omega-3 Fatty Acids
      • Olezarsen for the treatment of hypertriglyceridemia and familial chylomicronemia syndrome
  • Metabolic diseases
    • DEFINITION OF METABOLIC SYNDROME
      • Prevalence of Metabolic Syndrome
      • Cardiovascular Risk in Metabolic Syndrome
      • SPISE (Single Point Insulin Sensitivity Estimator) Screening of High-Risk Patients
      • SPISE (Single Point Insulin Sensitivity Estimator) Calculator
      • HOMA Index -Screening of High-Risk Patients
      • Homa Index Calculator
    • Obesity
      • Obesity Classification
      • Epidemiology and Causes of Obesity
        • Comorbidities and Obesity-Related Complications
        • Impaired Carbohydrate Metabolism
        • Dyslipidemia in Obesity
        • Obesity and Cardiovascular Risk
        • Gout and Obesity
        • Obesity and Hormonal Disorders in Women: Hyperandrogenism, Polycystic Ovary Syndrome (PCOS), and Pregnancy Complications
        • Hormonal Disorders in Men: Obesity-Related Hypogonadism
        • Impaired Immune Function and Respiratory Consequences of Obesity
        • Obesity and Pulmonary Complications
        • Obesity and Cholelithiasis and Acute and Chronic Cholecystitis
        • Obesity and Liver Disease
        • Obesity and Gastroesophageal Reflux Disease
        • Obesity and Degenerative Disorders of the Musculoskeletal System: Osteoarthritis
        • Obesity and Cancer Risk
    • Obesity Management
      • Management of Obesity: Prerequisites and Baseline Assessment
      • Physical Activity and Exercise in the Treatment of Obesity
      • Nutritional Interventions in the Treatment of Obesity
      • Pharmacological Treatment of Obesity
    • Steatotic Liver Disease
      • MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)
      • Management of MASLD
      • MASH (Metabolic Dysfunction-Associated Steatohepatitis)
      • Resmetirom: First Approved Pharmacological Therapy for MASH
    • Gout
      • Diagnosis of gout
      • Differential Diagnosis of Gout
      • Treatment of Acute Gout Attacks
    • Phenylketonuria
      • Dietary Therapy
      • Examples of Daily Meal Plans for Phenylketonuria
      • Amino Acid Mixtures
      • Sapropterin (BH4) Pharmacological Therapy (for Suitable Patients)
    • Amyloidosis
      • ATTR Amyloidosis
      • Treatment of Cardiac Transthyretin Amyloidosis (ATTR-CM)
  • Diabetes
    • Diagnosis of Diabetes Mellitus
    • What is Diabetes
    • What is Type 1 Diabetes Mellitus?
      • Conventional Insulin Therapy (CT) for Type 1 Diabetes
      • Intensified Conventional Insulin Therapy (ICT)
      • Insulin Pump Therapy (CSII – Continuous Subcutaneous Insulin Infusion)
      • Technical Options of Insulin Pump Therapy
        • Insulin Pumps
        • Glucose Sensor Systems
      • When Hormones Influence Blood Glucose
    • Type 2 Diabetes Mellitus
      • Therapeutic Goal in Type 2 Diabetes: Weight Reduction
      • Typ 2 Diabetes and Weight Gain
      • Body Mass Index (BMI) Classification and BMI Calculator
      • Weight Loss Helps with Type 2 Diabetes
      • Pharmacological Therapy Typ 2 Diabetes
      • Metformin
      • Glucose Monitoring (CGM) in Type 2 Diabetes
      • Treatment of High-Risk Patients with GLP-1 Agonists
      • Treatment of High-Risk Patients with : SGLT2 inhibitors
      • Treatment Pathway for Patients Without ASCVD, CKD, or HF
      • Cancer The Leading Cause of Death in Type 2 Diabetes
      • Cancer Risk Reduction in T2DM
      • Metformin and Cancer
      • Insulin Therapy in Type 2 Diabetes
      • Types of Insulin and Insulin Action
      • Insulin
    • Gestational Diabetes Diabetes Typ 4
    • Diabetes Mellitus Typ 3
    • Diabetes Typ 5
    • Self-Monitoring
      • Methods for Self-Monitoring of Blood Glucose
      • Self-Monitoring Through Spot Blood Glucose Measurements
      • Who should measure their blood glucose and how often?
      • Continuous Glucose Monitoring (rtCGM)
      • Technology of Continuous Glucose Monitoring (rtCGM)
      • Measurement Accuracy of Real-Time Continuous Glucose Monitoring Systems (rtCGM)
      • Self-monitoring of blood pressure
      • Self-Monitoring of Ketone Bodies
      • Self-Monitoring of the Feet in Diabetes
      • Self-Checking of Injection Sites in Diabetes Patients on Insulin Therapy
    • Diabetes in children and adolescents
      • Diabetes in childhood and adolescence progresses through different phases.
      • Treatment of Diabetes in Children
    • Gestational Diabetes
    • Pregnant with Type 1 Diabetes
    • Acute Complications
      • Hypoglycemia (Low Blood Sugar)
      • Hyperglycemia (elevated blood glucose levels), ketoacidosis, and coma
    • Secondary Complications
      • Diabetes and Cancer
      • Study Results: Choosing the Right Medications Saves Lives!
      • Cardiovascular and Vascular Diseases in Diabetes
      • Lipid Therapy in Older Patients With Diabetes
      • Diabetes and Kidney Disease
      • Lower Urinary Tract Syndrome (LUTS)
        • Urge Incontinence
        • Stress Incontinence
      • Genitourinary Syndrome of Women
      • Diabetes and Eye Diseases
      • Diabetes and Nerve Disorders
      • Diabetes and the Skin
      • Diabetic foot syndrome
        • Prevention of Diabetic Foot Syndrome
        • Causes of diabetic foot injuries
        • Wound Therapy for Diabetic Foot Syndrome
        • Peripheral Arterial Disease (Circulatory Disorder)
    • Comorbidities
      • Diabetes and Hypertension
      • What Are the Consequences of High Blood Pressure?
      • Causes of Hypertension
      • Self-Monitoring of Blood Pressure
      • Lowering Blood Pressure Through Lifestyle Changes
      • Effective Medication Treatment for Hypertension
      • Blood Pressure in Patients with Diabetes Should Not Be Too Low
    • Diabetes and Sexuality
      • What Is Meant by Sexual Dysfunction?
      •  Examinations for Sexual Dysfunction in men
      • Sexual Dysfunction in Men
      • Treatment Options for Sexual Dysfunction in Men
      • Nutrients and Supplements for Erectile Dysfunction (ED): Evidence Overview
      • Testosterone Deficiency in Older Men
      • Sexual Dysfunction in Women with Diabetes
      • Treatments for female sexual dysfunction
        • Flibanserin for acquired, generalized hypoactive sexual desire disorder (HSDD)
        • Bremelanotide increases sexual desire
      • Diabetes and Relationships
      • Contraception and Diabetes
  • News
    • Amyloidosis – An Often Overlooked Disease with New Diagnostic and Treatment Options
    • Three medicinal products for the treatment of lipid disorders
    • Olezarsen for the treatment of hypertriglyceridemia
    • Clascoterone for the treatment of acne
    • French female athletes have been excluded from the World Championship by the World Boxing Federation.
    • Archive
  • Hypthalamus and puitary
    • Function of the Hypophysis
    • Acromegaly
    • Prolactinoma
    • Cushing’s Disease
    • Pituitary Adenomas
    • Craniopharyngiomas
    • Anterior Pituitary Insufficiency
      • Growth Hormone Deficiency (GHD) in Children
      • Growth hormone deficiency (GHD)
    • Diabetes Insipidus
    • SIADH (Syndrome of Inappropriate Antidiuretic Hormone Secretion)
  • Adrenals
    • Cushing’s Syndrome
    • Adrenal Cortex Carcinoma (Cushing’s Carcinoma)
    • Classical CAH (Congenital Adrenal Hyperplasia)
    • Adrenogenital Syndrome
    • Hyperaldosteronism
    • Pheochromocytoma
    • Adrenal Insufficiency
    • Adrenal Tumors
  • Thyroid
    • Cold nodules
    • Thyroid Cancer
    • Autonomous Adenoma
    • Hyperfunction (Hyperthyroidism)
      • Graves’ Disease (M. Basedow)
      • Endocrine Orbitopathy (EO)
    • Hypothyroidism (Hypothyreosis)
    • Chronic Autoimmune Thyroiditis (Hashimoto’s Thyroiditis)
    • Other Thyroid Inflammations
  • Parathyroid
    • Primary Hyperparathyroidism (pHPT)
    • Secondary Hyperparathyroidism (sHPT)
    • Tertiary Hyperparathyroidism (tHPT)
    • Neonatal Severe Hyperparathyroidism (NSHPT)
    • Hypercalcemia with Suppressed PTH
    • Hypoparathyroidism
    • Pseudo-Hypoparathyroidism (PHP)
    • Familial Hypocalciuric Hypercalcemia (FHH)
    • Autosomal Dominant Hypocalcemia (ADH)
  • Gonads
    • Testes (Male Gonads)
    • Hypergonadotropic Hypogonadism in Men
    • Testicular Tumors
    • Androgen Insensitivity
    • Ovaries
    • Amenorrhea
    • Polyendocrine Metabolic Ovarian Syndrome (PMOS)
    • Premature Ovarian Insufficiency (POI)
    • Functional Hypothalamic Amenorrhea (FHA)
    • Contraception
    • Precocious Puberty (Pubertas Praecox) in Girls
    • Delayed Puberty
    • Menopause
    • Developmental Disorders of Sex Differentiation
    • Sport and XY-DSD (Disorders of Sex Development)
    • Klinefelter Syndrome
    • Gender Incongruence trans women
    • Gender Incongruence trans men
    • Libido
    • Androgen Deficiency in Women
    • Clascoterone
    • Infertility
      • AMH (Anti-Müllerian Hormone),IVF, ICSI
      • Kisspeptin and Neurokinin B (NKB)
  • Neuroendocrine Tumor
    • Multiple Endokrine Neoplasien (MEN)
  • Osteoporosis
    • Osteoporosis: Screening and Diagnosis
    • Osteoporosistherapy
    • Exercises
    • Medications for Osteoporosis
    • Postmenopausal women
    • Osteoporosis in Men
    • Kyphoplasty
  • Lipidology
    • Epidemiology
    • Types of Lipid Metabolism Disorders
    • Who should be treated with a metabolic lipid disorder?
    • Cardiovascular Risk
      • Risk Management for Patients with Diabetes Mellitus
      • Risk Assessment Cardiovascular Disease
      • Lipid Therapy and Age
      • Unstable Plaques
    • Lipoproteins
    • Pharmacological Therapy
      • Statins
        • Adverse Effects of Statins
      • Ezetimibe
      • Bempedoic acid
      • Anion Exchange Resins
      • PCSK9 Inhibitors
      • PCSK9 synthesis inhibitor
      • Lyrokaul® (Lerodalcibep)
      • Obicetrapib
      • Fibrates
      • Omega-3 Fatty Acids
      • Olezarsen for the treatment of hypertriglyceridemia and familial chylomicronemia syndrome
  • Metabolic diseases
    • DEFINITION OF METABOLIC SYNDROME
      • Prevalence of Metabolic Syndrome
      • Cardiovascular Risk in Metabolic Syndrome
      • SPISE (Single Point Insulin Sensitivity Estimator) Screening of High-Risk Patients
      • SPISE (Single Point Insulin Sensitivity Estimator) Calculator
      • HOMA Index -Screening of High-Risk Patients
      • Homa Index Calculator
    • Obesity
      • Obesity Classification
      • Epidemiology and Causes of Obesity
        • Comorbidities and Obesity-Related Complications
        • Impaired Carbohydrate Metabolism
        • Dyslipidemia in Obesity
        • Obesity and Cardiovascular Risk
        • Gout and Obesity
        • Obesity and Hormonal Disorders in Women: Hyperandrogenism, Polycystic Ovary Syndrome (PCOS), and Pregnancy Complications
        • Hormonal Disorders in Men: Obesity-Related Hypogonadism
        • Impaired Immune Function and Respiratory Consequences of Obesity
        • Obesity and Pulmonary Complications
        • Obesity and Cholelithiasis and Acute and Chronic Cholecystitis
        • Obesity and Liver Disease
        • Obesity and Gastroesophageal Reflux Disease
        • Obesity and Degenerative Disorders of the Musculoskeletal System: Osteoarthritis
        • Obesity and Cancer Risk
    • Obesity Management
      • Management of Obesity: Prerequisites and Baseline Assessment
      • Physical Activity and Exercise in the Treatment of Obesity
      • Nutritional Interventions in the Treatment of Obesity
      • Pharmacological Treatment of Obesity
    • Steatotic Liver Disease
      • MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)
      • Management of MASLD
      • MASH (Metabolic Dysfunction-Associated Steatohepatitis)
      • Resmetirom: First Approved Pharmacological Therapy for MASH
    • Gout
      • Diagnosis of gout
      • Differential Diagnosis of Gout
      • Treatment of Acute Gout Attacks
    • Phenylketonuria
      • Dietary Therapy
      • Examples of Daily Meal Plans for Phenylketonuria
      • Amino Acid Mixtures
      • Sapropterin (BH4) Pharmacological Therapy (for Suitable Patients)
    • Amyloidosis
      • ATTR Amyloidosis
      • Treatment of Cardiac Transthyretin Amyloidosis (ATTR-CM)
  • Diabetes
    • Diagnosis of Diabetes Mellitus
    • What is Diabetes
    • What is Type 1 Diabetes Mellitus?
      • Conventional Insulin Therapy (CT) for Type 1 Diabetes
      • Intensified Conventional Insulin Therapy (ICT)
      • Insulin Pump Therapy (CSII – Continuous Subcutaneous Insulin Infusion)
      • Technical Options of Insulin Pump Therapy
        • Insulin Pumps
        • Glucose Sensor Systems
      • When Hormones Influence Blood Glucose
    • Type 2 Diabetes Mellitus
      • Therapeutic Goal in Type 2 Diabetes: Weight Reduction
      • Typ 2 Diabetes and Weight Gain
      • Body Mass Index (BMI) Classification and BMI Calculator
      • Weight Loss Helps with Type 2 Diabetes
      • Pharmacological Therapy Typ 2 Diabetes
      • Metformin
      • Glucose Monitoring (CGM) in Type 2 Diabetes
      • Treatment of High-Risk Patients with GLP-1 Agonists
      • Treatment of High-Risk Patients with : SGLT2 inhibitors
      • Treatment Pathway for Patients Without ASCVD, CKD, or HF
      • Cancer The Leading Cause of Death in Type 2 Diabetes
      • Cancer Risk Reduction in T2DM
      • Metformin and Cancer
      • Insulin Therapy in Type 2 Diabetes
      • Types of Insulin and Insulin Action
      • Insulin
    • Gestational Diabetes Diabetes Typ 4
    • Diabetes Mellitus Typ 3
    • Diabetes Typ 5
    • Self-Monitoring
      • Methods for Self-Monitoring of Blood Glucose
      • Self-Monitoring Through Spot Blood Glucose Measurements
      • Who should measure their blood glucose and how often?
      • Continuous Glucose Monitoring (rtCGM)
      • Technology of Continuous Glucose Monitoring (rtCGM)
      • Measurement Accuracy of Real-Time Continuous Glucose Monitoring Systems (rtCGM)
      • Self-monitoring of blood pressure
      • Self-Monitoring of Ketone Bodies
      • Self-Monitoring of the Feet in Diabetes
      • Self-Checking of Injection Sites in Diabetes Patients on Insulin Therapy
    • Diabetes in children and adolescents
      • Diabetes in childhood and adolescence progresses through different phases.
      • Treatment of Diabetes in Children
    • Gestational Diabetes
    • Pregnant with Type 1 Diabetes
    • Acute Complications
      • Hypoglycemia (Low Blood Sugar)
      • Hyperglycemia (elevated blood glucose levels), ketoacidosis, and coma
    • Secondary Complications
      • Diabetes and Cancer
      • Study Results: Choosing the Right Medications Saves Lives!
      • Cardiovascular and Vascular Diseases in Diabetes
      • Lipid Therapy in Older Patients With Diabetes
      • Diabetes and Kidney Disease
      • Lower Urinary Tract Syndrome (LUTS)
        • Urge Incontinence
        • Stress Incontinence
      • Genitourinary Syndrome of Women
      • Diabetes and Eye Diseases
      • Diabetes and Nerve Disorders
      • Diabetes and the Skin
      • Diabetic foot syndrome
        • Prevention of Diabetic Foot Syndrome
        • Causes of diabetic foot injuries
        • Wound Therapy for Diabetic Foot Syndrome
        • Peripheral Arterial Disease (Circulatory Disorder)
    • Comorbidities
      • Diabetes and Hypertension
      • What Are the Consequences of High Blood Pressure?
      • Causes of Hypertension
      • Self-Monitoring of Blood Pressure
      • Lowering Blood Pressure Through Lifestyle Changes
      • Effective Medication Treatment for Hypertension
      • Blood Pressure in Patients with Diabetes Should Not Be Too Low
    • Diabetes and Sexuality
      • What Is Meant by Sexual Dysfunction?
      •  Examinations for Sexual Dysfunction in men
      • Sexual Dysfunction in Men
      • Treatment Options for Sexual Dysfunction in Men
      • Nutrients and Supplements for Erectile Dysfunction (ED): Evidence Overview
      • Testosterone Deficiency in Older Men
      • Sexual Dysfunction in Women with Diabetes
      • Treatments for female sexual dysfunction
        • Flibanserin for acquired, generalized hypoactive sexual desire disorder (HSDD)
        • Bremelanotide increases sexual desire
      • Diabetes and Relationships
      • Contraception and Diabetes

Gonads

  • Privacy policy
  • Datenschutzerklärung
  • Imprint
  • Impressum
  • Contact
  • Privacy policy
  • Datenschutzerklärung
  • Imprint
  • Impressum
  • Contact